1,581 results on '"Nakanishi, Yoichi"'
Search Results
302. Recurrent idiopathic pulmonary hemosiderosis after long-term remission presented with Sjogren's syndrome: Idiopathic no more?
303. Purification of zebrafish erythrocytes as a means of identifying a novel regulator of haematopoiesis
304. Interleukin-22 attenuates double-stranded RNA-induced upregulation of PD-L1 in airway epithelial cells via a STAT3-dependent mechanism
305. CD44 variant–dependent regulation of redox balance in EGFR mutation–positive non–small cell lung cancer: A target for treatment
306. Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma
307. Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1
308. Safety Profile of Nivolumab in Japanese NSCLC Pts: Interim Results from Post-marketing All-Case Surveillance in Japan
309. Dectin-1 intracellular domain determines species-specific ligand spectrum by modulating receptor sensitivity
310. Autocrine Growth Factors and Lung Cancer
311. Introduction to the International Activities of the Center for Clinical and Translational Research, Kyushu University
312. Establishing A Hub of International Cooperation Through The Japan Medical Innovation Tour
313. Promoting The Development of Human Resources Through The Department of Research and Development of Next Generation Medicine
314. RAS-related protein is a novel regulator of erythropoiesis
315. Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial
316. P2-208 - Current progress and issues of cancer genomic medicine in Kyushu University Hospital
317. Depletion of club cells attenuates bleomycin-induced lung injury and fibrosis in mice
318. 5. Present State of Molecular Target Drug for Lung Cancer
319. Introduction
320. Treatment with a programmed cell death-1-specific antibody has little effect on afatinib- and naphthalene-induced acute pneumonitis in mice
321. Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
322. Twist1 regulates embryonic hematopoietic differentiation through binding to Myb and Gata2 promoter regions
323. Expression of cytokine and extracellular matrix mRNAs in fetal hepatic stellate cells
324. Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer
325. Visualization and quantitation of epidermal growth factor receptor homodimerization and activation with a proximity ligation assay
326. Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring EGFR mutations
327. Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease
328. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4
329. Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non–small cell lung cancer
330. Nivolumab-induced interstitial lung disease (ILD) in Japanese patients with non-small cell lung cancer: A study on risk factors using interim results of post-marketing all-case surveillance.
331. Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer
332. Probucol attenuates hyperoxia-induced lung injury in mice
333. Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in mice
334. Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan
335. Amphiregulin suppresses epithelial cell apoptosis in lipopolysaccharide-induced lung injury in mice
336. Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
337. Effects of corticosteroid plus long-acting beta2-agonist on the expression of PD-L1 in double-stranded RNA-induced lung inflammation in mice
338. Association of Airflow Limitation With Carotid Atherosclerosis in a Japanese Community ― The Hisayama Study ―
339. A case of sarcoidosis with mediastinal lymph node tuberculosis
340. P2.08-007 Listen Advocate Voice - Web-Survey for the Japanese Model of Lung Cancer Advocacy by Society
341. Laparoscopic Extraction of a Bezoar Impacted in the Small Intestine after Cola Lavage and Endoscopic Treatment—A Case Report—
342. Haigan
343. P3.05-007 Prospective Evaluation for Combination Antiemetic Therapy on CINV in NSCLC Receiving Carboplatin-Based Chemotherapy of MEC
344. P2.03a-056 Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non–Small Cell Lung Cancer: KTOSG Trial 1301
345. A case of immunoglobulin G4-related respiratory disease with multiple lung cysts: A case report
346. SC13.04 Limitations by COPD for Treatment
347. P3.02c-001 Phase I Study of Salazosulfapyridine Targeting Cancer Stem Cells in Combination with CDDP and Pemetrexed for Chemo-Naïve Advanced Non-Sq NSCLC
348. Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
349. MA08.10 Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
350. Association between genetic polymorphisms involved in the hypoxia-inducible factor pathway and lung cancer risk: a case-control study in Japan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.